Approximately 15%-40% of children born to HIV-1 seropositive mothers will be infected, and the prognosis for these infants is poor. Factors that determine whether or not a child becomes infected are currently not understood, and methods for early diagnosis of HIV infection in neonates need to be established. The major goals of this study are a) evaluation of newly developed methods for early detection of HIV-1 infection in infants, b) comparison of maternal and infant viral antigenic determinants, and c) investigation of maternal and neonatal humoral responses in relation to the occurrence of perinatal transmission of HIV-1. Methods to be studied for early detection include measurement of infant IgA anti-HIV-l antibody in sera by ELISA and Western blot assays, detection of in vitro antibody production, virus isolation from CD8+-depleted infant PBMC, and PCR detection of proviral DNA. Molecular studies will address which maternal HIV-1 quasi-species are perinatally transmitted, and compare antigenic regions from maternal and infant viruses. Maternal and infant viral env regions encoding the V3 loop will be amplified from PBMC by PCR, cloned and sequenced to obtain consensus and variant V3 sequences. These mother and infant V3 sequences will be used for synthesis of peptides in studies focused on the role of maternal antibodies to the V3 region of gpl2O. We will measure maternal and infant seroreactivity to these V3 peptides with ELISA assays designed to assess affinity/avidity. Knowledge of the V3 sequences in the mother and/or infected infant is required to accurately assess the role of V3 directed antibodies in virus transmission. There is some urgency to resolve this question. If indeed V3 reactivity serves as a marker for infant protection this would be useful for targeting infants as candidates for interventive therapeutics as well as suggesting other immune based interventive strategies. The role of specific HIV-1 neutralizing antibodies will be investigated in relation to perinatal transmission. Maternal and infant sera will be assayed for their ability to neutralize both maternal- and infant-derived viral isolates. With a better understanding of factors influencing the transmission of HIV-1 from mother to child, strategies for intervention can be developed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032393-04
Application #
2067262
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1991-09-30
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1996-07-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Collins-Fairclough, Aneisha M; Charurat, Manhattan; Nadai, Yuka et al. (2011) Significantly longer envelope V2 loops are characteristic of heterosexually transmitted subtype B HIV-1 in Trinidad. PLoS One 6:e19995
Chen, C H; Greenberg, M L; Bolognesi, D P et al. (2000) Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41. AIDS Res Hum Retroviruses 16:2037-41
Cleghorn, F R; Jack, N; Carr, J K et al. (2000) A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A 97:10532-7
Lacey, S F; Weinhold, K J; Chen, C H et al. (1998) Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual. AIDS Res Hum Retroviruses 14:521-31
Greenberg, M L; Lacey, S F; Chen, C H et al. (1997) Noncytolytic CD8 T cell-mediated suppression of HIV replication. Springer Semin Immunopathol 18:355-69
Anstey, N M; Tissot Dupont, H; Hahn, C G et al. (1997) Seroepidemiology of Rickettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. Am J Trop Med Hyg 57:187-9
Lacey, S F; McDanal, C B; Horuk, R et al. (1997) The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1. Proc Natl Acad Sci U S A 94:9842-7
Chen, C H; Matthews, T J; McDanal, C B et al. (1995) A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol 69:3771-7
Matthews, T J; Wild, C; Chen, C H et al. (1994) Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol Rev 140:93-104
Chen, C H; Weinhold, K J; Bartlett, J A et al. (1993) CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses 9:1079-86